Bayer Group Consolidated Statements of Recognized Income and Expense

	2006	2007
€ million
Changes in fair values of derivatives designated as hedges, recognized in stockholders’ equity	(59)	180
Changes in fair values of derivatives designated as hedges, recognized in the income statement	11	(65)
Changes in fair values of available-for-sale financial assets, recognized in stockholders’ equity	(7)	31
Recognition of available-for-sale financial assets in the income statement	-	(8)
Changes in actuarial gains/losses on defined benefit obligations for pensions and other post-employment benefits and effects of the limitation on pension plan assets, recognized in stockholders’ equity	448	1,355
Exchange differences on translation of operations outside the euro zone, recognized in stockholders’ equity	(725)	(825)
Deferred taxes on valuation adjustments offset directly against stockholders’ equity	(148)	(677)
Deferred taxes on valuation adjustments, removed from stockholders’ equity and recognized in the income statement	3	20
Changes due to changes in the scope of consolidation	-	42
Minority interest in partnerships, recognized in liabilities	-	(36)
Valuation adjustments recognized directly in stockholders’ equity	(477)	17
of which attributable to minority interest	(5)	(3)
Income after taxes	1,695	4,716
Total income and expense recognized in the financial statements	1,218	4,733
of which attributable to minority interest	7	2
of which attributable to Bayer AG stockholders	1,211	4,731